根据股骨头负重区判断非创伤性股骨头坏死带塌陷生存

doi:10.3877/cma.j.issn.1674-134X.2024.03.002

中华关节外科杂志(电子版) ›› 2024, Vol. 18 ›› Issue (03) : 307 -313. doi: 10.3877/cma.j.issn.1674-134X.2024.03.002

临床论著

根据股骨头负重区判断非创伤性股骨头坏死带塌陷生存

江梦钰¹, 陈志文¹, 胡云浩¹, 凡一诺², 方汉军³, 刘予豪³, 王海彬³, 何伟⁴, 陈镇秋³, 周驰⁵^,^†(

)

^1. 510499　广州中医药大学第一临床医学院
^2. 510080　广州中医药大学第三临床医学院
^3. 510405　广州中医药大学第一附属医院
^4. 510378　广州中医药大学第三附属医院
^5. 510405　广州中医药大学第一附属医院;525000　广州中医药大学（茂名市中医院）

收稿日期:2023-11-27 出版日期:2024-06-01
通信作者: 周驰

Judging on survival of non-traumatic femoral head necrosis zone collapse according to weight-bearing area of femoral head

Mengyu Jiang¹, Zhiwen Chen¹, Yunhao Hu¹, Yinuo Fan², Hanjun Fang³, Yuhao Liu³, Haibin Wang³, Wei He⁴, Zhenqiu Chen³, Chi Zhou⁵^,^†()

^1. The First Clinical of Medical School of Guangzhou University of Chinese Medicine, Guangzhou 510499, China
^2. The Third Clinical of Medical Schoolof Guangzhou University of Chinese Medicine, Guangzhou 510080, China
^3. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China
^4. The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510378, China
^5. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China;Maoming Hospital of Guangzhou University of Chinese Medicine, Maoming 525000, China

Received:2023-11-27 Published:2024-06-01
Corresponding author: Chi Zhou

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

江梦钰, 陈志文, 胡云浩, 凡一诺, 方汉军, 刘予豪, 王海彬, 何伟, 陈镇秋, 周驰. 根据股骨头负重区判断非创伤性股骨头坏死带塌陷生存[J]. 中华关节外科杂志(电子版), 2024, 18(03): 307-313.

Mengyu Jiang, Zhiwen Chen, Yunhao Hu, Yinuo Fan, Hanjun Fang, Yuhao Liu, Haibin Wang, Wei He, Zhenqiu Chen, Chi Zhou. Judging on survival of non-traumatic femoral head necrosis zone collapse according to weight-bearing area of femoral head[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2024, 18(03): 307-313.

目的

本研究旨在通过股骨头负重区完整率来探讨股骨头坏死（ONFH）“带塌陷生存”的条件，评估其诊断国际骨循环研究协会（ARCO ⅢA）期患者结局的可靠性。

方法

选择广州中医药大学第一附属医院（2010年至2017年）的非创伤性股骨头坏死患者中属于ARCO ⅢA期“带塌陷”的患者，拥有正常沟通能力，临床就诊影像学资料完整，知情同意，定期复查。同时排除患有其他严重慢性病史的老年患者，影像学资料不完整、用药不当、进行全髋关节置换术或保髋手术患者。通过日本骨坏死研究会（JIC）分型对进行分类，根据结局分为塌陷进展组和带塌陷生存组。通过X线平片的标准正位（AP）和蛙位（FL）测量外侧股骨头负重区完整率（APIR）和前侧股骨头负重区完整率（FLIR），并明确该指标与结局的关系。然后通过单因素和多因素logistic回归分析确定塌陷进展的危险因素，最后采用受试者工作特征（ROC）曲线分析负重区完整率对塌陷进展和带塌陷生存诊断的可靠性。

结果

共纳入72例（90髋）ARCO ⅢA期ONFH患者，其中带塌陷生存37髋随访时间85（72，166）个月，塌陷进展53髋随访时间24（6，78）个月；JIC分型（χ²=21.312，P<0.001）是影响“带塌陷生存”的因素；ROC曲线分析结果显示，APIR的临界值为16.6%［线下面积（AUC）=91.0%，Youden指数=0.78，P<0.000 1）］，即APIR≥16.6%时与带塌陷生存相关；FLIR 的临界值为16.1%（AUC=89.7%，Youden指数=0.82，P<0.000 1），即FLIR≥16.1%时与带塌陷生存相关。该结果提示APIR和FLIR与结局相关。

结论

前外侧股骨头负重区完整率与带塌陷生存密切相关，提示ARCOⅢA期ONFH患者可根据APIR和FLIR判断是否符合“带塌陷生存”的条件，以此合理选择治疗手段。

关键词: 股骨头, 坏死, 负重, 预后

Objective

To explore the condition of "survival with collapse" of femoral head necrosis (ONFH) and evaluate its reliability in diagnosing the outcome of patients with International Association Research Circulation Osseous (ARCO) stage ⅢA by using the integrity rate of femoral head weight-bearing area.

Methods

Patients with non-traumatic femoral head necrosis in the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from 2010 to 2017 who belonged to ARCO stage ⅢA "with collapse" were selected. The enrolled patients had normal communication skills, complete imaging data of clinical visits, informed consent and were regular followed up. The elderly patients with other severe chronic diseases, the patients with incomplete imaging data, inappropriate medication and history of total hip arthroplasty or hip-preserving surgery were excluded. The patients were categorised by the Japan Investigation Committee (JIC) type, and divided into the collapse progression group and the survival with collapse group according to the outcome. Anteroposterior-view intact ratio (APIR) and frog-leg view intact ratio(FLIR) were measured by standard anteroposterior view(AP) and frog-leg view (FL) of radiograph, the relationship between this index and the outcome was clarified. Univariate and multivariate logistic regression analyses were then performed to identify risk factors for progression of collapse. The reliability of weight-bearing zone integrity on the diagnosis of collapse progression and survival with collapse was analyzed using the receiver operating characteristic (ROC) curve.

Results

A total of 72 patients (90 hips) with ONFH of ARCO stage ⅢA were enrolled. Among them, 37 hips survived with collapse were followed up for 85(72, 166)months , and 53 hips with collapse progression were followed up for 24 (6, 78) months. JIC type was the key influent factor of the survival with collapse (χ²=21.312, P<0.001). ROC curve analysis showed that the critical value of APIR was 16.6%［area under curve(AUC)=91.0%, Youden index=0.78, P<0.0001］. APIR≥16.6% was significantly related to survival with collapse. The critical value of FLIR was 16.1% (AUC=89. 7% , Youden exponent = 0.82, P<0.001), which suggested that FLIR≥ 16.1% was significantly related to survival with collapse. APIR and FLIR were significantly correlated with the outcome.

Conclusion

The anterolateral femoral head weight-bearing area integrity rate is closely related to "survival with collapse", which suggests that patients with ONFH of ARCO stage ⅢA can be judged whether they are eligible for "survival with collapse" according to the APIR and FLIR, so as to rationally choose the treatment.

Key words: Femoral head, Necrosis, Weight-bearing, Prognosis

图1 股骨头负重区完整率的测量方法注：C点为髋臼最外缘，F点为泪滴最低点，CF线中垂线与髋臼交于D点；以C点为中心作地面垂线与股骨头相交于A点，B点是坏死区累及股骨头壁的外侧边界；弧长（AB）代表股骨头在负重部分非坏死区域的长度，弧长（CD）表示承重部分髋臼的轮廓长度；左图示APIR（外侧股骨头负重区完整率）=弧长（AB）／弧长（CD）×100%；右图示FLIR（前侧股骨头负重区完整率）=弧长（AB）／弧长（C-D）×100%

Figure 1 Measurement of integrity rate of weight-bearing area of femoral head Note: Point C is the outermost edge of the acetabulum, point F is the lowest point of the teardrop, and point D is the intersection of the vertical line of the midpoint of the CF line and the acetabulum. The vertical line with the central axis through point C intersects the femoral head at point A, and B is the outer boundary of the necrotic area involving the wall of the femoral head. Arc length AB represents the contour length of the femoral head in the non-necrotic area of the weight-bearing part. Arc length CD represents the contour length of the acetabulum in the weight-bearing part.The left figure shows APIR（anteroposterior-view intact ratio）= arc length AB/ arc length CD×100%; the right figure shows FLIR (frog-leg view intact ratio)= arc length AB/ arc length CD×100%

图2 JIC（日本骨坏死调查委员会）分型影像图注：左、中、右图分别为JIC分型B型、C1型和C2型的X线片

Figure 2 JIC(Japanese Investigation Committee) typing image map Note: Left, middle and right figures are X-ray images of JIC type

表1 ARCO ⅢA期股骨头坏死相关资料与带塌陷生存的相关性

Table 1 Correlation between the data of femoral head necrosis of ARCO ⅢA and the survival with collapse

组别 Groups	髋数 Number of hips	性别（髋） Gender (hip)		随访时长［个月，M（P₂₅，P₇₅）］ Follow-up time（month）	年龄分组（例） Age grouping
组别 Groups	髋数 Number of hips	男 Male	女 Female	随访时长［个月，M（P₂₅，P₇₅）］ Follow-up time（month）	18～35岁	36～55岁	>55岁
塌陷进展组 Collapse progression group	53	39	14	24（6，78）	25	25	3
带塌陷生存组 Survival with collapse group	37	23	14	85（72,166）	19	17	1
统计值 Statistical values		χ²=1.327		Z=-6.621	χ²=0.488
P值		>0.05		<0.001	>0.05
组别 Groups	髋数 Number of hips	病因（髋） Causes（hip）			JIC分型（髋） JIC type（hip）
组别 Groups	髋数 Number of hips	激素 Corticosteroid	酒精 Alcohol	特发 Idiopathic	B	C1	C2
塌陷进展组 Collapse progression group	53	26	23	4	1	32	20
带塌陷生存组 Survival with collapse group	37	25	10	2	7	29	1
χ²值		3.031			21.312
P值		>0.05			<0.001

表1 ARCO ⅢA期股骨头坏死相关资料与带塌陷生存的相关性

Table 1 Correlation between the data of femoral head necrosis of ARCO ⅢA and the survival with collapse

组别 Groups	髋数 Number of hips	性别（髋） Gender (hip)		随访时长［个月，M（P₂₅，P₇₅）］ Follow-up time（month）	年龄分组（例） Age grouping
组别 Groups	髋数 Number of hips	男 Male	女 Female	随访时长［个月，M（P₂₅，P₇₅）］ Follow-up time（month）	18～35岁	36～55岁	>55岁
塌陷进展组 Collapse progression group	53	39	14	24（6，78）	25	25	3
带塌陷生存组 Survival with collapse group	37	23	14	85（72,166）	19	17	1
统计值 Statistical values		χ²=1.327		Z=-6.621	χ²=0.488
P值		>0.05		<0.001	>0.05
组别 Groups	髋数 Number of hips	病因（髋） Causes（hip）			JIC分型（髋） JIC type（hip）
组别 Groups	髋数 Number of hips	激素 Corticosteroid	酒精 Alcohol	特发 Idiopathic	B	C1	C2
塌陷进展组 Collapse progression group	53	26	23	4	1	32	20
带塌陷生存组 Survival with collapse group	37	25	10	2	7	29	1
χ²值		3.031			21.312
P值		>0.05			<0.001

表2 APIR、FLIR与ARCO ⅢA期股骨头结局的关系［%,M（P₂₅，P₇₅）］

Table 2 Relationship between APIR、FLIR and the femoral head outcome in ARCOⅢA stage

	髋数 Number of hips	负重区完整率 Integrity rate of weight-bearing area	Z值	P值
APIR
塌陷进展组Collapse progression group	31	12.4（8.9，16.0）	-5.674	<0.001
带塌陷生存组Survival with collapse group	34	23.3（18.8，31.3）	-5.674	<0.001
FLIR
塌陷进展组Collapse progression group	31	7.9（2.1，13.6）	-5.490	<0.001
带塌陷生存组Survival with collapse group	34	21.7（17.3，29.2）	-5.490	<0.001

表2 APIR、FLIR与ARCO ⅢA期股骨头结局的关系［%,M（P₂₅，P₇₅）］

Table 2 Relationship between APIR、FLIR and the femoral head outcome in ARCOⅢA stage

	髋数 Number of hips	负重区完整率 Integrity rate of weight-bearing area	Z值	P值
APIR
塌陷进展组Collapse progression group	31	12.4（8.9，16.0）	-5.674	<0.001
带塌陷生存组Survival with collapse group	34	23.3（18.8，31.3）	-5.674	<0.001
FLIR
塌陷进展组Collapse progression group	31	7.9（2.1，13.6）	-5.490	<0.001
带塌陷生存组Survival with collapse group	34	21.7（17.3，29.2）	-5.490	<0.001

表3 前外侧股骨头负重区完整率的ROC曲线分析

Table 3 ROC curve of weight-bearing area integrity rate of anterolateral femoral head

	界值(%) Boundary value	AUC (%)	95%置信区间 95% confidence interval	Youden 指数 Youden index	P值
APIR	16.6	91.0	（0.828，0.991）	0.78	<0.001
FLIR	16.1	89.7	（0.797，0.997）	0.82	<0.001

表3 前外侧股骨头负重区完整率的ROC曲线分析

Table 3 ROC curve of weight-bearing area integrity rate of anterolateral femoral head

	界值(%) Boundary value	AUC (%)	95%置信区间 95% confidence interval	Youden 指数 Youden index	P值
APIR	16.6	91.0	（0.828，0.991）	0.78	<0.001
FLIR	16.1	89.7	（0.797，0.997）	0.82	<0.001

图3 APIR（外侧股骨头负重区完整率）和FLIR（前侧股骨头负重区完整率）的ROC（受试者工作特征）曲线分析

Figure 3 ROC(receiver operating characteristic) curve analysis of APIR(anteroposterior-view intact ratio) and FLIR(frog-leg view intact ratio)

［1］	孙伟，高福强，李子荣. 股骨头坏死临床药物防治专家共识（2022年）［J］. 中国骨伤，2023,36(8): 724-730.
［2］	Sodhi N，Acuna A，Etcheson J，et al. Management of osteonecrosis of the femoral head［J］. Bone Joint J，2020,102-B(7_Supple_B): 122-128.
［3］	吴健钮，吴洁，李益亮. 中医药治疗创伤性股骨头坏死的研究进展［J］. 中国医药科学，2023,13(12): 27-30.
［4］	Mont MA，Salem HS，Piuzzi NS，et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today？: a 5-year update［J］. J Bone Joint Surg Am，2020,102(12): 1084-1099.
［5］	Cui Q，Jo WL，Koo KH，et al. ARCO consensus on the pathogenesis of non-traumatic osteonecrosis of thefemoral head［J/OL］. J Korean Med Sci，2021,36(10): e65. DOI:10.3346/jkms.2021.36.e65.
［6］	Mont MA，Jones LC，Einhorn TA，et al. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors［J］. Clin Orthop Relat Res，1998(355 Suppl): S314-S335.
［7］	Hu LB，Huang ZG，Wei HY，et al. Osteonecrosis of the femoral head: using CT，MRI and gross specimen to characterize the location，shape and size of the lesion［J/OL］. Br J Radiol，2015,88(1046): 20140508. DOI:10.1259/bjr.20140508.
［8］	Zhao EZ，Liu ZH，Zeng WN，et al. Nomogram to predict collapse-free survival after core decompression of nontraumatic osteonecrosis of the femoral head［J/OL］. J Orthop Surg Res，2021,16(1): 519. DOI: 10.1186/s13018-021-02664-3.
［9］	Zheng GS，Qiu X，Wang BJ，et al. Relationship between blood flow and collapse of nontraumatic osteonecrosis of the femoral head［J］. J Bone Joint Surg Am，2022,104(Suppl 2): 13-18.
［10］	朱诗白，张啸天，陈曦，等. 股骨头坏死的保髋治疗［J/CD］. 中华关节外科杂志（电子版），2020,14(6): 741-746.
［11］	何伟. 精确诊断前提下股骨头坏死非手术治疗实践［J］. 临床外科杂志，2017,25(8): 580-582.
［12］	Zhao DW，Yu M，Hu K，et al. Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population: results from a nationally representative survey［J］. Chin Med J，2015,128(21): 2843-2850.
［13］	陈晓东. “保髋” 之路将越走越宽［J/CD］. 中华关节外科杂志（电子版），2017,11(3): 219-221.
［14］	孙伟，高福强，李子荣. 股骨头坏死临床诊疗技术专家共识（2022年）［J］. 中国修复重建外科杂志，2022,36(11): 1319-1326.
［15］	谭彪. 中医药治疗中晚期股骨头坏死“带塌陷生存” 疗效分析及相关影响因素研究［D］. 北京: 中国中医科学院，2022.
［16］	Rowan FE，Benjamin B，Pietrak JR，et al.Preventionof dislocation after total hip arthroplasty［J］. J Arthroplasty，2018,33(5): 1316-1324.
［17］	Cao H，Guan H，Lai Y，et al. Review of various treatment options and potential therapies for osteonecrosis of the femoral head［J］. J Orthop Translat，2016,4: 57-70.
［18］	Fan Y，Liu X，Zhong Y，et al. Evaluation of the predictive values of collapse and necrotic lesion boundary for osteonecrosis of the femoral head prognosis［J/OL］. Front Endocrinol，2023,14: 1137786. DOI:10.3389/fendo.2023.1137786.
［19］	Fan Y，Zhang J，Chen M，et al. Diagnostic value of necrotic lesion boundary in bone collapse of femoral head osteonecrosis［J］. Int Orthop，2022,46(3): 423-431.
［20］	Jiang Y，Liu C，Chen W，et al. Tetramethylpyrazine enhances vascularization and prevents osteonecrosis in steroid-treated rats［J/OL］. Biomed Res Int，2015,2015: 315850. DOI:10.1155/2015/315850.
［21］	Kubo Y，Motomura G，Ikemura S，et al. Effect of collapse on the deformity of the femoral head-neck junction in osteonecrosis of the femoral head［J］. Arch Orthop Trauma Surg，2017,137(7): 933-938.
［22］	Rezus E，Tamba BI，Badescu MC，et al. Osteonecrosis of the femoral head in patients with hypercoagulability-from pathophysiology to therapeutic implications［J/OL］. Int J Mol Sci，2021,22(13): 6801. DOI:10.3390/ijms22136801.
［23］	Zhao D，Zhang F，Wang B，et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults（2019 version）［J］. J Orthop Translat，2020,21: 100-110.
［24］	Gangji V，Toungouz M，Hauzeur JP. Stem cell therapy for osteonecrosis of the femoral head［J］. Expert Opin Biol Ther，2005,5(4): 437-442.
［25］	Hong YC，Luo RB，Lin T，et al. Efficacy of alendronate for preventing collapse of femoral head in adult patients with nontraumatic osteonecrosis［J/OL］. Biomed Res Int，2014,2014: 716538. DOI:10.1155/2014/716538.
［26］	李获，王鹏，高健明，等. 股骨头坏死血运重建与内部微观结构改变的关系［J］. 中国组织工程研究，2022,26(9): 1323-1328.
［27］	Petek D，Hannouche D，Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment［J］. EFORT Open Rev，2019,4(3): 85-97.
［28］	Pritzker KPH，Gay S，Jimenez SA，et al. Osteoarthritis cartilage histopathology: grading and staging［J］. Osteoarthritis Cartilage，2006,14(1): 13-29.
［29］	Ansari S，Goyal T，Kalia RB，et al. Prediction of collapse in femoral head osteonecrosis: role of volumetric assessment［J］. Hip Int，2022,32(5): 596-603.
［30］	何伟. 如何把握股骨头坏死患者的保髋治疗时机［J］. 中国骨与关节杂志，2016,5(2): 82-86.
［31］	Wang W，Yu JN，Tao XJ. Systemic lupus erythematosus complicated with femoral head ischemic necrosis treated by Chinese medicine therapy for activating blood and dredging collaterals method［J］. Chin J Integr Med，2011,17(2): 105-110.
［32］	王豪. 股骨头坏死ARCOⅢ期不同塌陷程度下两种保髋手术方式治疗的临床疗效探究［D］. 南宁: 广西中医药大学，2022.
［33］	Ha YC，Jung WH，Kim JR，et al. Prediction of collapse in femoral head osteonecrosis: a modified Kerboul method with use of magnetic resonance images［J］. J Bone Joint Surg Am，2006,88(Suppl 3): 35-40.
［34］	袁强，董一平，张宁，等. 不同SBTOCS分型的股骨头坏死患者保髋治疗后股骨头塌陷、头臼匹配度、髋关节稳定度对比观察［J］. 山东医药，2022,62(15): 61-64.
［35］	颜新昊. 股骨头前、外侧壁保留角与股骨头坏死塌陷的相关性研究［D］. 广州: 广州中医药大学，2021.
［36］	Lee TC，Taylor D. Bone remodelling: should we cry Wolff？［J］. Ir J Med Sci，1999,168(2): 102-105.
［37］	Utsunomiya T，Motomura G，Yamaguchi R，et al. Effects of the location of both anterior and lateral boundaries of the necrotic lesion on collapse progression in osteonecrosis of the femoral head［J］. J Orthop Sci，2024,29(2): 552-558.
［38］	Nishii T，Sugano N，Ohzono K，et al. Significance of lesion size and location in the prediction of collapse of osteonecrosis of the femoral head: a new three-dimensional quantification using magnetic resonance imaging［J］. J Orthop Res，2002,20(1): 130-136.
［39］	Kubo Y，Motomura G，Ikemura S，et al. Effects of anterior boundary of the necrotic lesion on the progressive collapse after varus osteotomy for osteonecrosis of the femoral head［J］. J Orthop Sci，2020,25(1): 145-151.
［40］	邹许亭. “围塌陷期” 理论指导下非创伤性股骨头坏死中医药治疗临床研究［D］. 广州: 广州中医药大学，2018.
［41］	贾晓军，欧志学，庞智晖，等. 何伟教授对于股骨头坏死围塌陷期保髋的创新认识和经验总结［J］. 中医正骨，2011,23(12): 76-78.
［42］	庞智晖，何伟. 基于临床和影像的股骨头坏死围塌陷期“微观辨证论治体系” 的构建［J/CD］. 中华关节外科杂志（电子版），2013,7(3): 363-368.
［43］	Zhou G，Zhang Y，Zeng L，et al. Should thorough debridement be used in fibular allograft with impaction bone grafting to treat femoral head necrosis: a biomechanical evaluation［J/OL］. BMC Musculoskelet Disord，2015,16: 140. DOI:10.1186/s12891-015-0593-3.

[1]	伍梦妮, 徐志华, 陈彦. DTNBP1基因在三阴性乳腺癌中的作用及其预后价值[J]. 中华乳腺病杂志(电子版), 2024, 18(03): 158-168.
[2]	廖泽楷, 梁爱琳, 龚启梅. 根尖周病中程序性细胞死亡的研究进展[J]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 150-155.
[3]	孙姚承, 汤建军, 张伟元, 刘传磊. 阳性淋巴结比和阳性淋巴结对数比对结直肠癌患者预后价值的研究[J]. 中华普通外科学文献(电子版), 2024, 18(03): 204-208.
[4]	蔡大明, 陆晓峰, 王行舟, 王萌, 刘颂, 夏雪峰, 沈晓菲, 杜峻峰, 管文贤. 三级淋巴结构在胃神经内分泌瘤中的预后价值及预后预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 401-405.
[5]	达热拜·热达提, 刘林, 赵为民, 孟涛, 雷程, 金博, 毕建军, 李新宇, 王海江. 中低位直肠癌新辅助放化疗后侧方淋巴结清扫术的临床观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 415-418.
[6]	李娇娇, 张军, 徐顺. 全程新辅助治疗联合全直肠系膜切除术对局部进展期直肠癌预后的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 283-286.
[7]	王东阳, 林琳, 娄熙彬. SII对局部进展期胃癌nCRT＋腹腔镜胃癌根治术后并发症及预后的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 315-318.
[8]	聂彬, 赵铁军, 于云宝, 李欢, 谢林峻. 单孔加一孔腹腔镜手术与传统腹腔镜手术治疗乙状结肠癌的疗效与分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 330-333.
[9]	韩智君, 李春, 艾力江·吾斯满, 帕合尔丁·买买提, 韩勇桥, 塔依尔·塔里甫, 西尔扎提·吐尔地. 三镜与双镜联合清创术在感染坏死性胰腺炎中应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 342-345.
[10]	周慧宇, 吕定阳, 双卫兵. 联合系统性免疫炎症指数和预后营养指数预测腹腔镜肾切除术后肾癌患者的预后[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 225-231.
[11]	曾谣, 谢琴, 陈显育, 王平根, 毛玲秋, 何丹玲, 杜飞, 郑希彦, 何函樨. CDC42EP2基因与肝癌预后、免疫细胞浸润关系及其对细胞迁移侵袭的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 363-369.
[12]	王春霞, 赵丽霞, 张迪, 张洪来, 张维胜, 王涛, 杨熊飞. 肛周坏死性筋膜炎伴腹膜后延伸一例病例报道[J]. 中华结直肠疾病电子杂志, 2024, 13(03): 256-259.
[13]	王小龙, 吴杰, 段姝伟, 王超卉, 潘娜, 白圆圆, 李航天, 蔡广研. 不同等级体力活动对慢性肾脏病患者预后的影响[J]. 中华肾病研究电子杂志, 2024, 13(03): 121-128.
[14]	安亚楠, 王端然, 郭甜甜, 武希润. 幽门螺杆菌阴性胃黏膜相关淋巴组织淋巴瘤的研究进展[J]. 中华消化病与影像杂志(电子版), 2024, 14(03): 268-274.
[15]	杨巨顺, 何伯圣. 急性肠系膜缺血不可逆肠坏死预测因素的研究进展[J]. 中华消化病与影像杂志(电子版), 2024, 14(03): 275-281.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Judging on survival of non-traumatic femoral head necrosis zone collapse according to weight-bearing area of femoral head

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Judging on survival of non-traumatic femoral head necrosis zone collapse according to weight-bearing area of femoral head